Loading insider details...
Beta
Latest Form 4 (Sep 3, 2026): Grant/Award of 7,405 BIIB shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 3, 2026 | BIOGEN INC. (BIIB) | Grant/Award | 7,405 | n/a |
| Feb 26, 2021 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Tax Withholding | 2,416 | $525.6K |
| Feb 19, 2021 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Tax Withholding | 6,240 | $1.32M |
| Feb 16, 2021 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Sale | 3,818 | $803.4K |
| Feb 12, 2021 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Tax Withholding | 2,563 | $548.9K |
| Feb 10, 2021 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Exercise/Conversion | 1,930 | $167.0K |
| Feb 5, 2021 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Grant/Award | 8,438 | n/a |
| Nov 18, 2020 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Sale | 26 | $5.8K |
| Nov 6, 2020 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Exercise/Conversion | 2,330 | $201.6K |
| Aug 10, 2020 | VERTEX PHARMACEUTICALS INC / MA (VRTX) | Exercise/Conversion | 1,223 | $190.3K |